key words | Vol. No. | page | @ | report |
Identification | Vol.77 No.08 | 539-546 | Yutaka FUKASAWA | Microplate Hybridization Methods of Reduced Unspecific Reassociation Considering TM -Comparison between Relative Relatedness of DNA and Key Characters for Mycobacterium szulgai |
Identification | Vol.77 No.08 | 547-554 | Yutaka FUKASAWA | Relative Relatedness of 11 Mycobacteria Species by Microplate Hybridization Methods Considering Tm |
Identification | Vol.83 No.1 | 43-59 | Chairpersons:T.TAKASHIMA & T.HIGUCHI | Mycobacterial Tests |
Identification of mycobacteria | Vol.81 No.09 | 551-558 | Yuko KAZUMI et al. | Identification of Mycobacteria by Sequencing of rpoB Gene and 16S rRNA |
IFD | Vol.85 No.6 | 515-522, | Saburo YAMAMOTO | CpG Motif and Tuberculosis Immunity |
IFN- | Vol.77 No.05 | 409-413 | Katsuhiko TSUKAGUCHI et al. | Longitudinal Assessment of IFN-Production in Patients with Pulmonary Tuberculosis Complicated with Diabetes Mellitus |
IFN- | Vol.77 No.08 | 585-588 | Isamu SUGAWARA | Study on the Roles of Cytokines Involved in Mycobacterial Infection |
IFN- | Vol.78 No.07 | 479-482 | Toshinobu YOKOYAMA et al. | Tuberculosis in Elderly |
IFN- | Vol.78 No.07 | 483-486 | Toshinobu YOKOYAMA et al. | Tuberculosis in Patients Undergoing Hemodialysis |
IFN- | Vol.79 No.12 | 725-735 | Nobuyuki HARADA et al. | Basic Characteristics of a Novel Diagnostic Method (QuantiFERON® TB-2G) of Latent Tuberculosis Infection with a Use of Mycobacterium tuberculsis-Specific Antigens, ESAT-6 and CFP-10 |
IFN- | Vol.79 No.4 | 289-295 | Keisuke AOE et al. | Diagnosis and Treatment of Tuberculous Pleurisy-With Special Reference to the Significance of Measurement of Pleural Fluid Cytokines- |
IFN- | Vol.81 No.11 | 687-691 | Ikuo KAWAMURA | Protective Immunity against Mycobacterium tuberculosis |
IGRA | Vol.86 No.12 | 983-1003 | Chairpersons: 1 Nobuyuki HARADA and 2 Yoshihiko HOSHINO | The 86th Annual Meeting Mini-Symposium - NEW MOVEMENT OF IGRA |
IGRA | Vol.88 No.04 | 411-416 | Haruko KAZAMA et al. | CONTACT INVESTIGATION USING QuantiFERON-TB R Gold TEST TO EVALUATE TB EXPOSURE IN 61 SUBJECTS IN A HOSPITAL SETTING (2) Change in QuantiFERON Response during One Year after Exposure |
IGRAs | Vol.86 No.07 | 743-749 | Nobuyuki HARADA | A VIEW OF DYNAMICS OF IMMUNE RESPONSES AGAINST TUBERCULOSIS INFECTION THROUGH QFT |
IL-18 | Vol.77 No.02 | 87-93 | Kenji NAKANISHI | Regulation of Th1 and Th2 Immune Responses by IL-18 |
IL-18 | Vol.78 No.6 | 443-448 | Rei FUJIKI et al. | A Case of Hemophagocytic Syndrome Associated with Miliary Tuberculosis |
Ileostomy | Vol.77 No.08 | 563-567 | Fuminobu KURODA et al. | A Case of Perforative peritonitis Complicated with Lung and Intestinal Severe Tuberculosis |
Ileus | Vol.81 No.04 | 345-349 | Masahiro SHIRAI et al. | A Case of Severe Intestinal Tuberculosis, Treated with Ciprofloxacin, Kanamycin and Prednisolone |
Ileus | Vol.82 No.12 | 919-923 | Norihiko IDA et al. | A Surgically Treated Case of
Ileus Caused by Small Intestinal Tuberculosis during Treatment for Pulmonary Tuberculosis |
Immune reconstitution inflammatory syndrome | Vol.86 No.01 | 1-8 | Kenji HIBIYA et al. | MECHANISMS INVOLVED IN THE EXTENSION OF PULMONARY MYCOBACTERIUM AVIUM INFECTION FROM THE PULMONARY FOCUS TO THE REGIONAL LYMPH NODES |
Immune reconstitution syndrome | Vol.78 No.1 | 45-49 | Hideaki NAGAI | HIV Infection and Tuberculosis |
Immune reconstitution syndrome | Vol.82 No.1 | 27-31 | Hirokazu TANIGUCHI et al. | A Case of Tuberculosis Showing Immune Reconstitution Syndrome after the Initiation of Antiretroviral Therapy for HIV Infection |
Immune reconstitution syndrome | Vol.86 No.05 | 509-514 | Harutaka OMURA et al. | A CASE OF PULMONARY TUBERCULOSIS WITH DIMINISHED LUNG FUNCTION WHOSE PARADOXICAL REACTION LED TO DEATH |
Immune response | Vol.86 No.12 | 983-1003 | Chairpersons: 1 Nobuyuki HARADA and 2 Yoshihiko HOSHINO | The 86th Annual Meeting Mini-Symposium - NEW MOVEMENT OF IGRA |
Immunity | Vol.79 No.5 | 341-348 | Naohiro NAGAYAMA et al. | Leukopenia Due to Anti-Tuberculous Chemotherapy Including Rifampicin and Isoniazid |
Immunity | Vol.87 No.02 | 61-70 | Kiyoko S. AKAGAWA | The 86th Annual Meeting Educational Lecture - RECENT ADVANCES IN TUBERCULOSIS IMMUNITY |
Immunity against M.TB | Vol.85 No.6 | 501-508, | Masaji OKADA | Immunity against Mycobacterium Tuberculosis (INTRODUCTION) |
Immunity and allergy | Vol.75 No.10 | 595-598 | Tadamitsu KISHIMOTO | Immunology in the 20th Century-Progress Made in Research on Infectious and Immunological Diseases |
Immunoadjunctive therapy | Vol.81 No.12 | 753-774 | Chairpersons:H. TOMIOKA and K. NAMBA | Development of Antituberculous Drugs:Current Status and Future Prospects |
ImmunoCard Mycoplasma test (IC) | Vol.88 No.04 | 423-427 | Kazuyoshi NAKAMURA et al. | A CASE OF TUBERCULOUS PLEURISY DISTINGUISHED FROM PLEURISY CAUSED BY MYCOPLASMA INFECTION |
Immunochromatographic assay | Vol.78 No.08 | 541-551 | Chiyoji ABE | Standardization of Laboratory Tests for Tuberculosis and Their Proficiency Testing |
Immunocompetent adult | Vol.87 No.10 | 659-662 | Tatsuyoshi IKEUE et al. | CERVICAL LYMPHADENITIS CAUSED BY MYCOBACTERIUM AVIUM IN AN IMMUNOCOMPETENT ADULT |
Immunocompromised host | Vol.77 No.02 | 51-59 | Yuka SASAKI et al. | Tuberculosis in the Patients Undergoing Haemodialysis in Japan, 1996 |
Immunocompromised host | Vol.78 No.4 | 353-358 | Hiromi TOMIOKA et al. | Problems about the Management of Active Pulmonary Tuberculosis Patients Undergoing Haemodialysis-Our Experiences and Nation-wide Questionnaire Survey- |
Immunocompromised host | Vol.84 No.10 | 681-684 | Rika KOIKE et al. | A Case of Multiple-Drug-Resistant Pulmonary Tuberculosis in a Hemodialysis Hospital |
Immunocompromised host | Vol.85 No.09 | 691-695 | Takeshi KAWASAKI et al. | THE PRESENT SITUATION OF MEASURES AGAINST TUBERCULOSIS IN HEMODIALYSIS FACILITIES IN CHIBA PREFECTURE |
Immunocompromised patients | Vol.86 No.02 | 45-50 | Akihiro ITO et. al. | ANALYSIS OF USEFULNESS OF A WHOLE BLOOD INTERFERON GAMMA ASSAY (QuantiFERON® TB-2G) FOR DIAGNOSING ACTIVE TUBERCULOSIS IN IMMUNOCOMPROMISED PATIENTS |
Immunodeficiency | Vol.82 No.1 | 61-66 | Yoshiko KAWABE | Application and Problems of QuantiFERON®TB-2G for Tuberculosis Control Programs(2)Clinical Use of QuantiFERON®TB-2G |
Immunodeficiency | Vol.82 No.11 | 809-824 | Ichiro TOIDA et al. | Severe Adverse Reactions after Vaccination with Japanese BCG Vaccine: A Review |
Immunology | Vol.77 No.05 | 415-419 | Akira KISOHARA et al. | Thymoma Complicated with Miliary Tuberculosis |
Immunosuppressant | Vol.75 No.12 | 685-690 | Tetsuya KIUCHI | Liver Transplantation and Tuberculosis |
Immunosuppressant | Vol.77 No.06 | 465-470 | Masakuni FUJITA et al. | A Case of Cutaneous Tuberculosis Under Steroid & Immunosuppressant Therapy for Dermatomyositis |
Immunosuppressant | Vol.84 No.08 | 585-590 | Hiroshi TANAKA et al. | Differential Diagnosis of Pulmonary Mycobacterial Infection; Radiological Findings Mimicking Tuberculous or Nontuberculous Mycobacterial Pneumonia |
Immunosuppression | Vol.86 No.02 | 101-112 | Chairpersons: S. SATO and H. NAGAI |
THE CLINICAL APPLICATION OF QuantiFERON TB-2G: ITS USEFULNESS AND LIMITATIONS |
Immunosuppression | Vol.86 No.12 | 945-958 | Chairpersons: 1 Shoji KUDOH and 2 Yuka SASAKI | The 86th Annual Meeting Symposium - THE PRESENT STATUS AND PROBLEMS OF TUBERCULOSIS PROPOSED BY THE SPECIALIZED FIELDS |
Improvement | Vol.82 No.3 | 217-227 | Chairpersons:Ka.SUZUKI and T.HIGUCHI | Improvement of Routine Works and Quality Control in Mycobacterial Laboratory |
Improving rate of the chest X-ray | Vol.80 No.01 | 1-7 | Shu TAGA et al. | The Clinical Study on Efficacy of Clarithromycin, Levofloxacin, and Streptomycin for Pulmonary Mycobacterium avium-intracellulare Complex Infection |
Improving rate of the sputum conversion | Vol.80 No.01 | 1-7 | Shu TAGA et al. | The Clinical Study on Efficacy of Clarithromycin, Levofloxacin, and Streptomycin for Pulmonary Mycobacterium avium-intracellulare Complex Infection |
Improving rate of the symptoms | Vol.80 No.01 | 1-7 | Shu TAGA et al. | The Clinical Study on Efficacy of Clarithromycin, Levofloxacin, and Streptomycin for Pulmonary Mycobacterium avium-intracellulare Complex Infection |
In vitro antimycrobial activity | Vol.76 No.01 | 29-31 | Shin KAWAHARA et al. | In vitro Antimycobacterial Activities of a New Quinolone, Balofloxacin |
Incarceration | Vol.75 No.06 | 413-422 | Hidenori MASUYAMA et al. | On the Differences in Attitude and Awareness of Clinical Doctors, Health Administrators and Other Health Workers to Tuberculosis Treatment in Japan and the US |
Incidence | Vol.82 No.05 | 467-473 | Eriko SHIGETO et al. | A Survey of Anti-Tuberculosis Drug-Induced Severe Liver Injury in Japan |
Incidence | Vol.82 No.09 | 685-695 | Hitoshi HOSHINO et al. | Estimation of TB Incidence by Labor Status |
Incidence | Vol.85 No.01 | 61-64 | Tuberculosis Surveillance Center | TUBERCULOSIS ANNUAL REPORT
2008 Series 4. Elderly TB |
Incidence | Vol.85 No.09 | 697-702 | Hitoshi HOSHINO et al. | TRENDS IN TUBERCULOSIS INFECTION AMONG FOREIGNERS IN JAPAN ACCORDING TO WORK STATUS |
Incidence | Vol.86 No.07 | 737-741 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 \Series 4. Elderly TB\ |
Incidence of TB | Vol.87 No.11 | 697-699 | Lina YI et al. | CAN AN INDIVIDUAL WITH A POSITIVE BASELINE QuantiFERON® TEST RESULT DEVELOP ACTIVE TUBERCULOSIS? |
Incidence of Tuberculosis | Vol.76 No.04 | 371-375 | Mie KASAMATSU et al. | Analysis of Factors Related to the High Incidence of Tuberculosis in the City of Wakayama-Analysis According to Age Groups, and Sputum Test Results |
Incidence of tuberculosis | Vol.78 No.01 | 5-13 | Akira SHIMOUCHI et al. | The Incidence Rate of Active Pulmonary Tuberculosis among Adult Population with Fibrotic Lesions |
Incidence rate | Vol.77 No.04 | 329-339 | Masako OHMORI et al. | Discussing the Current Situation of Tuberculosis Case-Finding by Mass Miniature Radiography in Japan |
Incidence rate | Vol.79 No.08 | 481-486 | Fumio YAMAGISHI | Tuberculosis in the Elderly |
Incidence rate | Vol.82 No.02 | 85-93 | Masako OHMORI et al. | Current Epidemiological Situation of Tuberculosis in the Workplace:Considering the Risk of Tuberculosis among Nurses |
Incidence rate | Vol.83 No.01 | 1-6 | Takeo INOUE et al. | Tuberculosis among Nurses in Aichi Prefecture, Japan |
Incidence rate | Vol.84 No.10 | 693-696 | Tuberculosis Surveillance Center, RIT, JATA | Tuberculosis Annual Report 2008 - Series 1. Summary of TB Notification Statistics in 2008 - |
Incidence rate | Vol.86 No.02 | 127-130 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 Series 1. Summary of TB Notification Statistics in 2009 |
Incidence rate | Vol.87 No.06 | 481-485 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 (1) Summary of Tuberculosis Notifi cation Statistics in 2010 |
Incidence rate | Vol.88 No.01 | 1-7 | Nobuharu OHSHIMA et al. | CHRONOLOGICAL DECREASE OF TUBERCULOSIS INCIDENCE RATES BY ORGAN CLASSIFICATION BASED ON A BIRTH COHORT STUDY IN JAPAN, 1975-2005 |
Incidence rate of tuberculosis | Vol.77 No.07 | 503-512 | Naohiro NAGAYAMA et al. | Frequency of Previous Tuberculosis History in Patients with and Without Active Tuberculosis Admitted to Our Hospital in 1980-83 and in 1997-99 |
Incompliance | Vol.76 No.12 | 717-721 | Takenori YAGI et al. | Clinical Analysis of Multidrug-Resistant Tuberculosis |
Index case | Vol.84 No.06 | 491-497 | Akira SHIMOUCHI et al. | Evaluation of Tuberculosis Contact Investigation & Examination in Congregate Settings in Osaka City |
Index case | Vol.85 No.06 | 547-552, | Kenji MATSUMOTO et al | Tuberculosis@Infection@@Tuberculin Skin Test or QuantiFERON and Related Factors in Contact Investigations |
Index case | Vol.87 No.2 | 35-40 | Kenji MATSUMOTO et al. | EXAMINATION OF ONSET CASES IN CONTACT INVESTIGATION |
Index case rate | Vol.83 No.02 | 81-85 | Takeo INOUE et al. | Transmission of Tuberculosis from Smear-Negative Bacillus-Positive Pulmonary TB Patients |
Index case rate | Vol.86 No.05 | 493-498 | Takeo INOUE et al. | EPIDEMIOLOGICAL SIGNIFICANCE OF PATIENTS WITH EXTRA-PULMONARY TB A Study of 10,082 Patients with Tuberculosis |
Indication | Vol.85 No.10 | 757-760 | Eriko SHIGETO | THE CURRENT STATUS OF FLUOROQUINOLONES AND OTHER OFF-LABEL DRUG USE FOR TUBERCULOSIS IN JAPAN |
Indication for operation | Vol.76 No.10 | 649-656 | Noboru NAKANO et al. | Surgical Management of Non-Tuberculous Mycobacteriosis and Tuberculosis of the Lung |
Indication for surgery | Vol.77 No.12 | 805-813 | Yutsuki NAKAJIMA | Treatment for Multidrug-Resistant Tuberculosis in Japan |
Indonesian fishermen | Vol.78 No.6 | 449-452 | Hidemaro ONO et al. | Four Cases of Pulmonary Tuberculosis among Deep-Sea Fishermen |
Infant | Vol.76 No.05 | 407-411 | Shinya KONDO et al. | Infants 12 Month-Old or Less as a High Risk Group in Tuberculosis-Comparison of Clinical Data with Those in Children Aged One to Two Years- |
Infant | Vol.78 No.2 | 89-93 | Shinya KONDO et al. | Usefulness of Cranial and Chest Imaging in the Diagnosis of Tuberculous Meningitis among Infants and Young Children |
Infant | Vol.85 No.11 | 783-786 | Hitoshi HOSHINO | PRESENT ACTIVITY OF BCG AND LTBI TREATMENT FOR INFANTS IN JAPAN |
Infant tuberculosis | Vol.77 No.11 | 759-761 | Chairpersons:T. RIKIMARU, T. KAWASHIRO | Treatment for Tuberculosis In Difficult Situations |
Infants | Vol.78 No.12 | 747-750 | Shinya KONDO et al. | Infants and Children Who Developed Tuberculosis Following Contacts Investigation |
Infants aged less than one year old | Vol.78 No.4 | 347-351 | Shinya KONDO et al. | Predominant Location of Pulmonary Parenchymal Lesions of Tuberculosis Primary Complex in Infants Aged Less Than One Year |
Infants less than one year | Vol.78 No.1 | 1-3 | Shinya KONDO et al. | Difficulties in the Treatment of Tuberculosis in Infants |
Infection | Vol.76 No.02 | 83-91 | Jerrold J. ELLNER | The Human Immune Response to Mycobacterium tuberculosis Infection and Disease |
Infection caused by M.kansasii | Vol.76 No.07 | 525-531 | Yoshinari KITAHARA et al. | Pulmonary Mycobacterium kansasii Infection in the Southern Area of Fukuoka Prefecture |
Infection control | Vol.79 No.07 | 443-448 | Yoshiko KAWABE et al. | Evaluation of Quantitative Fit-Testing of N95 Filtering Facepiece Respirators Using Mask-Fitting Tester and lmprovement of Mask Fitting by instruction |
Infection control | Vol.79 No.9 | 569-571 | Norihiko NAKANISHI et al. | A Case of Pulmonary Tuberculosis in Late Stage of Pregnancy |
Infection control | Vol.80 No.12 | 743-747 | Akira SHIMOUCHI et al. | A Survey on Nosocomial Tuberculosis Infection Control in Hospitals in Osaka City |
Infection control | Vol.81 No.1 | 27-34 | Masakazu AOKI | Risk Management of Tuberculosis in Medical Institutions |
Infection control | Vol.81 No.1 | 27-34 | Masakazu AOKI | Risk Management of Tuberculosis in Medical Institutions |
Infection diagnosis | Vol.87 No.2 | 35-40 | Kenji MATSUMOTO et al. | EXAMINATION OF ONSET CASES IN CONTACT INVESTIGATION |
Infection risk | Vol.85 No.6 | 547-552, | Kenji MATSUMOTO et al | Tuberculosis@Infection@@Tuberculin Skin Test or QuantiFERON and Related Factors in Contact Investigations |
Infection risk | Vol.86 No.05 | 487-491 | Kenji MATSUMOTO et al. | AN OUTBREAK OF TUBERCULOSIS IN WHICH ENVIRONMENTAL FACTORS INFLUENCED TUBERCULOSIS INFECTION |
Infection risk index | Vol.79 No.12 | 693-703 | Masakazu AOKI | Transmission of Tuberculosis(U) |
Infection route | Vol.85 No.09 | 711-721 | Kenji HIBIYA et al. | THE PATHOGENESIS OF THE BOWEL INFECTION WITH THE MYCOBACTERIUM TUBERCULOSIS |
Infectious Diseases | Vol.86 No.04 | 459-471 | Kunihiko ITO | LEGAL ENFORCEMENT FOR NON-ADHERENT TUBERCULOSIS PATIENTS |
Infectious disease control | Vol.80 No.11 | 701-708 | Nobuhiko OKABE | Present Situation and Control on Emerging Respiratory Infectious Diseases Such as SARS and Avian Influenza |
Infectious Diseases Control Law | Vol.81 No.10 | 613-621 | Yasuhiro YOSHIKAWA | Tuberculosis as a Zoonosis |
Infectious Diseases Control Law | Vol.84 No.11 | 737-742 | Hideki YOTSUMOTO | Medical Economics in Tuberculosis Management: What will Come Next TB Ward? |
Infectious Disease's Control Law | Vol.87 No.02 | 51-55 | Kunihiko ITO et al. | NATIONWIDE SURVEY OF THE USE OF CLASS 2 INFECTIOUS DISEASE BEDS FOR IN-HOSPITAL CARE OF TUBERCULOSIS PATIENTS |
Infectious Diseases Law | Vol.81 No.12 | 737-743 | Tarou TSUKAHARA | The Tuberculosis Control Law of Japan:Current Issues and Prospect of Tuberculosis Control Plan |
Infectious sources | Vol.86 No.02 | 113-125 | Chairperson: Akira KAJIKI | NON-TUBERCULOUS MYCOBACTERIOSIS WHAT HAS BEEN COMING OUT |
Infectious tuberculous patients | Vol.77 No.12 | 777-782 | Shin SASAKI et al. | Smear-Positive Pulmonary Tuberculosis Diagnosed in a General Hospital |
Infectiousness | Vol.81 No.12 | 721-730 | Kunihiko ITO et al. | Criteria of Hospitalization and Discharge for Tuberculosis in the Western Developed Countries and Comparison with That of Japan |
Infectiousness | Vol.82 No.02 | 125-141 | Chairpersons:E.TOYOTA and K.OGAWA | The New Criteria for Discharge from Tuberculosis Ward-Practical Use and Problem |
Infectious-ness index of tuberculosis cases | Vol.82 No.05 | 459-466 | Eri TSUKISHIMA et al. | Association between Clustered Strain of M.tuberculosis and Infectiousness Index of Tuberculosis Cases in a Population-Based IS 6110-RFLP Analysis |
Infectivity | Vol.81 No.05 | 357-362 | Kunihiko ITO | Number of Concentrated Sputum Smears Needed to Adequately Assess Infectivity of Patients with Pulmonary Tuberculosis |
Infectivity of culture positive case | Vol.79 No.9 | 509-518 | Masakazu AOKI | Transmission of Tuberculosis(I) |
Infectivity of smear positive case | Vol.79 No.09 | 509-518 | Masakazu AOKI | Transmission of Tuberculosis(I) |
Infertility | Vol.76 No.06 | 473-478 | Seiyu HIRATA et al. | A Case of Tuberculous Endometritis Detected by Cytology of Mass Screening for Gynecologic Cancer |
Infiltrative shadow | Vol.85 No.08 | 667-671 | Kazumi NISHIO et al. | A CASE OF TUBERCULOUS PLEURISY WITH TRANSIENT NEW INTRA-PULMONARY LESIONS DURING ANTI-TUBERCULOSIS THERAPY |
Infliximab | Vol.80 No.10 | 647-653 | Fumio YAMAGISHI | Chemoprophylaxis |
Infliximab | Vol.86 No.11 | 879-882 | Tatsuyoshi IKEUE et al. | DEVELOPMENT OF CERVICAL TUBERCULOUS LYMPHADENITIS IN A PATIENT WITH CROHN'S DISEASE RECEIVING INFLIXIMAB DESPITE OF CHEMOPROPHYLAXIS WITH ISONIAZID |
Informations management | Vol.80 No.02 | 75-79 | Yoko NAKAZAWA | The Development of a Tuberculosis Informations Management System in Kanagawa Prefecture |
Informed consent | Vol.77 No.10 | 647-658 | Masako OHMORI et al. | Preventive Therapy in Middle-Aged and Elderly Persons Selected from the Population-Based Screening by Mass Miniature Radiography-Methodological Aspect and Adverse Reactions |
INH | Vol.76 No.05 | 427-436 | CSUCTNS | Clinical Study on the Cases in Which INH or RFP was Discontinued during Treatment for Pulmonary Tuberculosis |
INH | Vol.85 No.1 | 33-45 | Kosho YOSHIKAWA and Shuichi YANO | IMMUNOSUPPRESSIVE THERAPY AND TUBERCULOSIS |
INH | Vol.86 No.02 | 51-55 | Tomoaki NAKAZONO et.al. | LIVER DYSFUNCTION DURING TREATMENT OF LATENT TUBERCULOSIS INFECTION |
INH | Vol.87 No.04 | 351-355 | Tuberculosis Surveillance Center, RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2009 Series 9. Treatment of TB (2) |
INH 0.1 g/ml resistant M, tuberculosis | Vol.77 No.07 | 533-535 | Hiroko YOSHIDA et al. | A Study of INH 0.1g/ml Resistant M. tuberculosis Strains Assessed by BrothMIC MTB-1 Method |
inhA | Vol.86 No.07 | 697-702 | Kinuyo CHIKAMATSU et.al. | EVALUATION OF GenoType® MTBDRplus FOR THE DETECTION OF MULTI-DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS |
INH resistance-conferring mutation | Vol.81 No.12 | 709-713 | Hiromi ANO et al. | Resistance-Conferring Mutations of Mycobacterium tuberculosis Strains with Low Level Resistance to Isoniazid |
Inhibitory effect | Vol.79 No.5 | 333-339 | Kazue NAKANAGA et al. | Comparison of Inhibitory Effect of Rifalazil and Rifampicin against Mycobacterium ulcerans Infection Induced in Mice |
INH-resistance | Vol.78 No.10 | 611-617 | Wakana SAITO et al. | Characteristics and Treatment Outcomes of INH-Resistant or RFP-Resistant Tuberculosis |
Initial aggravation | Vol.86 No.08 | 757-761 | Hiroko OKAMOTO et al. | A CASE OF PLEURAL TUBERCULOMA WITH INTRA-PULMONARY INVASION DURING ANTI-TUBERCULOSIS THERAPY |
Innate Immunity | Vol.83 No.02 | 101-109 | Satoshi UEMATSU et al. | Innate Immunity and Tuberculosis |
Innate immunity | Vol.85 No.6 | 501-508, | Masaji OKADA | Immunity against Mycobacterium Tuberculosis (INTRODUCTION) |
In-service training | Vol.87 No.02 | 71-81 | Chairpersons: Yoko NAGATA and Keiko KUDO |
The 86th Annual Meeting Mini-Symposium ROLE OF NURSING IN TUBERCULOSIS CARE |
Insulin action | Vol.79 No.1 | 25-32 | Ryuzo KAWAMORI | Diabetes and Tuberculosis-Bad Companions- |
Insulin secretory dynamics | Vol.79 No.1 | 25-32 | Ryuzo KAWAMORI | Diabetes and Tuberculosis-Bad Companions- |
Interferon-Camma Release Assays | Vol.84 No.4 | 173-186 | Kazue HIGUCHI et al. | Research Agenda of Interferon-Gamma Release Assays |
Interferon-gamma | Vol.75 No.08 | 511-516 | Akira SUDA et al. | Study on the Tow-Step Tuberculin Tests and Gamma-Interferon Assays in Elderly Persons |
Interferon-gamma | Vol.80 No.12 | 773-784 | Chairperson:T. MORI | The Interferon-Test in Perspective |
Interferon-gamma assay | Vol.80 No.08 | 581-585 | Peter ANDERSEN et al. | Replacing the Tuberculin Skin Test with a Specific Blood Test |
Interferon-gamma release assays | Vol.85 No.1 | 17-31 | Tadayuki AHIKO and Kiminori SUZUKI | NOVEL DIAGNOSTIC TESTS FOR
TUBERCULOSIS INFECTION : THEIR PROBLEMS AND PERSPECTIVES |
Interferon-gamma release assays | Vol.86 No.11 | 869-877 | Riyo FUJIYAMA et al. | COMPARISON OF CONVENTIONAL TUBERCULIN SKIN TEST AND QFT-2G®, A NEW METHOD FOR DIAGNOSIS OF TUBERCULOSIS INFECTION, WITH THE USE OF THE CONTACT SCORE |
Interferon-gamma release assays (IGRA) | Vol.87 No.04 | 329-335 | Hideo YOSHIKAWA et.al. | REPRODUCIBILITY OF THE QFT-G-IT ASSAY IN THE CONTACT EXAMINATION IN WHICH A HIGH POSITIVE RATE WAS SHOWN INDEPENDENT OF CONTACT TIME |
Interferon-gamma release assays (IGRAs) | Vol.87 No.09 | 557-564 | Hideo YOSHIKAWA | POSSIBLE PRESENCE OF A BOOSTER
EFFECT IN PEOPLE REPEATEDLY EXPOSED TO MYCOBACTERIUM TUBERCULOSIS DEMONSTRATED IN A MYCOBACTERIUM TUBERCULOSIS-SPECIFIC INTERFERON-GAMMA RELEASE ASSAY |
Interferon- | Vol.79 No.9 | 541-545 | Kaoru SHIMOKATA | Tuberculous Infection and Biological Response in Man |
Interferon- | Vol.86 No.02 | 101-112 | Chairpersons: S. SATO and H. NAGAI |
THE CLINICAL APPLICATION OF QuantiFERON TB-2G: ITS USEFULNESS AND LIMITATIONS |
Interferon- | Vol.86 No.07 | 743-749 | Nobuyuki HARADA | A VIEW OF DYNAMICS OF IMMUNE RESPONSES AGAINST TUBERCULOSIS INFECTION THROUGH QFT |
Interferon- release assay | Vol.85 No.7 | 585-589, | Akira SHIMOUCHI et al. | Discussion on Evidence for Principle of Tuberculosis Contact Investigation - From the Experience in Osaka City - |
Intermittent chemotherapy | Vol.82 No.10 | 771-781 | Masako WADA | Anti-Tuberculosis Chemotherapy |
Intermittent treatment | Vol.79 No.02 | 59-61 | Chairpersons:Hideo OGATA and Takeko YAMASHITA | The Results of DOTS Strategy |
Intermittent treatment during continuation phase | Vol.81 No.05 | 363-369 | Masako WADA et al. | Twice-Weekly Intermittent Chemotherapy during the Maintenance Phase of the Short-Course Treatment for New Patients with Pulmonary Tuberculosis |
International network | Vol.77 No.10 | 671-677 | Jumpei YAMAMURA et al. | A Study on Patients with Tuberculosis Among Foreigners Overstayed in Japan After Expiration of Visa-Activities Over Three Years |
Interpretive compatibility | Vol.77 No.02 | 61-66 | Miyako Higa et al. | Interpretive Compatibility of Antimycobacterial Susceptibility for Mycobacterium tuberculosis Determined by Proportion Test Method on Egg-Based Ogawa Media and Broth Microdilution Test, BrothMIC MTB |
Interstitial pneumonia with collagen vascular disease | Vol.78 No.07 | 487-490 | Yoshihiro KOBASHI et al. | A case of Pulmonary Mycobacterium avium Complex Disease Complicated by Interstitial Pneumonia with Collagen Vascular Disease |
Intestinal tuberculosis | Vol.76 No.06 | 479-484 | Hiroshi MIZUTANI et al. | A case of Tuberculous Peritonitis Diagnosed by a Direct Smear of Ascitic Fluid Complicated with an Active Pulmonary Tuberculosis and Intestinal Tuberculosis |
Intestinal tuberculosis | Vol.77 No.04 | 355-360 | Hirofumi SUZUKI et al. | The Current Status and Problems of the Intestinal Tuberculosis Through a review of the Annual of the Pathological Autopsy Cases in Japan |
Intestinal tuberculosis | Vol.77 No.08 | 563-567 | Fuminobu KURODA et al. | A Case of Perforative peritonitis Complicated with Lung and Intestinal Severe Tuberculosis |
Intestinal tuberculosis | Vol.81 No.04 | 345-349 | Masahiro SHIRAI et al. | A Case of Severe Intestinal Tuberculosis, Treated with Ciprofloxacin, Kanamycin and Prednisolone |
Intestinal tuberculosis | Vol.85 No.09 | 711-721 | Kenji HIBIYA et al. | THE PATHOGENESIS OF THE BOWEL INFECTION WITH THE MYCOBACTERIUM TUBERCULOSIS |
Intracellular growth | Vol.76 No.02 | 53-57 | Katsumasa SATO et al. | Invasion and Intracellular Growth of Mycobacterium tuberculosis and Mycobacterium avium Complex Adapted to Intramacrophagic Environment within Macrophages and Type II Alveolar Epithelial Cells |
Intracellular parasite | Vol.81 No.08 | 543-549 | Akira WATANABE | Clinical Manifestation of Q Fever and Tuberculosis, Similarly Caused by Intracellular Parasites |
Intracellular parasitic bacteria | Vol.75 No.09 | 557-560 | Chairpersons:M. MITSUYAMA, K. SUZUKI | Mechanisms of Pathogenicity and Host Defense in Infections by Intracellular Parasitic Microbes |
Intracranial tuberculosis | Vol.81 No.05 | 375-379 | Shinya KONDO et al. | Three Cases of Tuberculosis Children Who Demonstrated Paradoxical Worsening during Different Stage of Treatment |
Intractable tuberculosis | Vol.76 No.12 | 741-747 | Atsushi SAITO | A Putative Immunotherapy with Biological Response Modifiers(BRM) against Intractable Pulmonary Tuberculosis |
Intrathoracic lymphoma | Vol.87 No.10 | 663-667 | Shojiro MINOMO et al. | ENLARGEMENT OF INTRATHORACIC DIFFUSE LARGE B-CELL LYMPHOMA DURING TREATMENT OF PULMONARY TUBERCULOSIS: A CASE REPORT |
Intra-familial TB transmission | Vol.84 No.06 | 477-484 | Takeo INOUE et al. | Generation-to-generation TB transmission in Aichi, Central Japan |
Intra-familial TB transmission | Vol.87 No.2 | 47-50 | Keiko MITAKA et al. | TWO CASES OF PULMONARY TUBERCULOSIS WITH AN INTRA-FAMILIAL TRANSMISSION ROUTE |
Intra-pulmonary invasion | Vol.86 No.08 | 757-761 | Hiroko OKAMOTO et al. | A CASE OF PLEURAL TUBERCULOMA WITH INTRA-PULMONARY INVASION DURING ANTI-TUBERCULOSIS THERAPY |
Invasion | Vol.75 No.11 | 649-659 | Kazue HIGUCHI et al. | The Invasion of Mycobacterium tuberculosis into Non-Phagocytic Cells |
Invasiveness | Vol.76 No.02 | 53-57 | Katsumasa SATO et al. | Invasion and Intracellular Growth of Mycobacterium tuberculosis and Mycobacterium avium Complex Adapted to Intramacrophagic Environment within Macrophages and Type II Alveolar Epithelial Cells |
Irregular life | Vol.75 No.04 | 349-353 | Makoto TAKAHARA et al. | A Clinical Study on Pulmonary Tuberculosis in Younger Age Groups |
IS901 | Vol.86 No.02 | 61-68 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
IS1245 | Vol.79 No.02 | 39-46 | Katsuhiro KUWABARA et al. | Relations between Clinical Subtypes of Mycobacterium avium Pulmonary Disease and Polyclonal Infections Detected by IS1245 Based Restriction Fragment Length Polymorphism Analysis |
IS1245 | Vol.79 No.9 | 519-523 | Katsuhiro KUWABARA et al. | Molecular Epidemiological Analysis by IS1245 Based Restriction Fragment Length Polymorphism Typing on Cases with Pulmonary Mycobacterium avium Disease Observed in the Same Family |
IS1245 | Vol.81 No.09 | 559-566 | Makoto MORIYAMA et al. | Usefulness of Variable Numbers of Tandem Repeats Typing in Clinical Strains of Mycobacterium avium |
IS6110 | Vol.77 No.11 | 741-752 | Mitsuyoshi TAKAHASHI | Molecular Epidemiology of Mycobacterium Tuberculosis:Its Accomplishment and Future Perspective |
IS6110 | Vol.82 No.12 | 925-927 | Shinji MAEDA et al. | Report of the Meeting for
Researchers in Charge of Tuberculosis Molecular Epidemiology in Japan, China and Korea |
IS6110 RFLP | Vol.81 No.04 | 321-328 | Hiromi ANO et al. | Molecular Epidemiology of Tuberculosis by the Use of IS6110 Restriction Fragment Length Polymorphism:A Study from 2001 to 2003 |
IS6110 RFLP | Vol.81 No.11 | 693-707 | Chairpersons:T. TAKASHIMA and T. IWAMOTO | A New Era of Molecular Epidemiology of Tuberculosis in Japan |
IS6110 RFLP | Vol.82 No.12 | 933-940 | Tomoshige MATSUMOTO | Molecular Epidemiology of Tuberculosis |
IS6110-RFLP | Vol.79 No.02 | 47-53 | Ritsuko OHATA et al. | Beijing Family and Other Genotypes of Mycobacterium tuberculosis Isolates in Okayama District |
IS6110-RFLP | Vol.82 No.6 | 531-538 | Shiomi YOSHIDA et al. | Molecular Epidemiology of Mycobacterium tuberculosis-Comparison between Mulltidrug-Resistant Strains and Susceptible Strains- |
IS901 | Vol.88 No.01 | 17-22 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
Ischemic cavity | Vol.81 No.02 | 63-69 | Seiyu HIRATA | A Case of Silicotuberculosis with Difficulty in Its Diagnosis |
ISMav6 | Vol.86 No.02 | 61-68 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
ISMav6 | Vol.87 No.05 | 433-448 | Chairpersons: Atsuyuki KURASHIMA and Kenji OGAWA | The 86th Annual Meeting Symposium FOREFRONT OF THE CLINIC AND RESEARCH OF PULMONARY MAC DISEASE |
ISMav6 | Vol.87 No.06 | 461-467 | Masaki NIIMI et al. | A STUDY OF GENETIC CHARACTERISTICS OF MYCOBACTERIUM AVIUM STRAINS FROM PATIENTS WITH PULMONARY M.AVIUM DISEASE IN JAPAN AND KOREA |
ISMav6 | Vol.87 No.11 | 687-695 | Taku NAKAGAWA et al. | MULTICENTER STUDY ON CLINICAL FEATURES AND GENETIC CHARACTERISTICS OF MYCOBACTERIUM AVIUM STRAINS FROM PATIENTS IN JAPAN WITH LUNG DISEASE CAUSED BY M.AVIUM |
ISMav6 | Vol.88 No.01 | 17-22 | Kenji OGAWA | GENETIC RESEARCH ABOUT MYCOBACTERIUM AVIUM COMPLEX |
ISO15189 | Vol.85 No.5 | 483-494, | Takeshi HIGUCHI and Satoshi MITARAI | New Technologies and Quality Assurance for the Diagnosis of Tuberculosis |
Isolation | Vol.79 No.06 | 387-390 | Kunihiko ITO et al. | Multi-Drug Resistant Lung Tuberculosis Due to Double Infection of MDR Strain |
Isolation | Vol.79 No.9 | 553-560 | Takashi YOSHIYAMA et al. | Estimation of the Number of Necessary Beds for Tuberculosis Patients, in Japan |
Isolation | Vol.80 No.1 | 31-45 | Chairpersons:H. NAGAI. T. INAGAKI | Tuberculosis and Human Rights |
Isolation from the family and the society | Vol.77 No.09 | 609-614 | Fumio YAMAGISHI et al. | The Present Situation of Daily Life of Tuberculosis Patients Treated in Hospitals with Beds for Tuberculosis in Japan |
Isoniazid | Vol.75 No.09 | 521-526 | Yoshihiro KOBASHI et al. | Desensitization Therapy for Antituberculous Drugs |
Isoniazid | Vol.77 No.08 | 569-571 | Kenji KAWAKAMI | Chemotherapy with Isoniazid and Rifampicin for Pulmonary Tuberculosis |
Isoniazid | Vol.77 No.10 | 647-658 | Masako OHMORI et al. | Preventive Therapy in Middle-Aged and Elderly Persons Selected from the Population-Based Screening by Mass Miniature Radiography-Methodological Aspect and Adverse Reactions |
Isoniazid | Vol.78 No.11 | 683-689 | Yuichiro SHISHIDO et al. | Agranulocytosis Due to Anti-Tuberculosis Drugs Including Isoniazid (INH) and Rifampicin (RFP)-A Report of Four Cases and Review of the Literature- |
Isoniazid | Vol.78 No.4 | 339-346 | Naohiro NAGAYAMA et al. | Secular Increase in the Incidence Rate of Drug-Induced Hepatitis Due to Anti-Tuberculosis Chemotherapy Including Isoniazid and Rifampicin |
Isoniazid | Vol.80 No.10 | 647-653 | Fumio YAMAGISHI | Chemoprophylaxis |
Isoniazid | Vol.81 No.11 | 651-660 | Kunihiko ITO et al. | Liver Damage in Treatment of Latent Tuberculous Infection by Isoniazid |
Isoniazid | Vol.82 No.1 | 1-9 | Kunihiko ITO et al. | Adverse Effect Other than Liver Dysfunction in Treatment of Latent Tuberculous Infection by Isoniazid |
Isoniazid | Vol.82 No.5 | 449-454 | Satoshi MITARAI et al. | Comparative Study of BACTEC MGIT 960 AST and Conventional Proportion Method Using Ogawa Medium for the Drug Susceptibility Testing of Mycobacterium tuberculosis to Isoniazid |
Isoniazid | Vol.78 No.5 | 401-406 | Hidekazu MATSUSHIMA et al. | A Case of Isoniazid Sodium Methanesulfonate Induced Interstitial Pneumonia |
Isoniazid | Vol.86 No.07 | 697-702 | Kinuyo CHIKAMATSU et.al. | EVALUATION OF GenoType® MTBDRplus FOR THE DETECTION OF MULTI-DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS |
Isoniazid | Vol.87 No.12 | 777-782 | Shinichi IWAMOTO et al. | A CASE OF ATYPICAL DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY ISONIAZID |
Isoniazid | Vol.88 No.04 | 439-443 | Tuberculosis Surveillance Center (TSC), RIT, JATA | TUBERCULOSIS ANNUAL REPORT 2010 (9) Treatment of Tuberculosis 2 |
Isoniazid mono resistance | Vol.80 No.1 | 9-14 | Takashi YOSHIYAMA et al. | Risk of Acquisition of RFP Resistance Out of INH Resistant RFP Susceptible Tuberculosis |
Isoniazid preventive therapy | Vol.75 No.11 | 629-641 | Takashi YOSHIYAMA | Cost Effectiveness Analysis of Isoniazid Preventive Therapy to the Contacts of Tuberculosis Patients under Japanese Settings |
Isoniazid sodium methanesulfonate | Vol.78 No.5 | 401-406 | Hidekazu MATSUSHIMA et al. | A Case of Isoniazid Sodium Methanesulfonate Induced Interstitial Pneumonia |
Isothermal and Chimeric preimerinitiated Amplification of Nucleic Acid | Vol.78 No.08 | 533-539 | Atsuyuki KURASHIMA et al. | Comparative Evaluation of the Isothermal and Chimeric Primer-Initiated Amplification of Nucleic Acids (ICAN®) and Roche Amplicor® PCR and Culture for Detecting Mycobacterium tuberculosis Complex in Sputum Samples |
ITCZ | Vol.82 No.2 | 143-147 | Atsuyuki KURASHIMA | Treatment of Non-Invasive Pulmonary Aspergillosis with New Anti-Fungal Drugs |
Itraconazole i.v. | Vol.78 No.12 | 757-763 | Shigeru KOHNO et al. | Pulmonary Aspergilloma, Diagnosis and Treatment |